0.0186EUR-7.00%Mkt Cap: 1.83M EURP/E: —Last update: 2026-06-01
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients with age-related diseases. The company'…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.83M EUR
Enterprise Value6.94M EUR
Revenue (TTM)—
Gross Profit0 EUR
Net Income (TTM)-8.03M EUR
Revenue/Share—
Last Price0.0186 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees19
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.01
PEG—
EV/EBITDA-0.88
EV/Revenue—
P/S—
P/B-0.06
EPS (TTM)-0.34
EPS (Forward)-2.15
52W Range
0.01532% of range0.2180
52W High0.2180 EUR
52W Low0.0153 EUR
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE—
ROA-66.56%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.64M EUR
CapEx (TTM)—
FCF Margin—
FCF Yield-89.39%
Net Debt6.51M EUR
Net Debt/EBITDA-0.83
Balance Sheet
Debt/Equity-0.68
Current Ratio0.35
Quick Ratio0.33
Book Value/Sh-0.3330 EUR
Cash/Share0.0520 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:400
Split DateMay 3, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.98.41M
Float23.36M
Insiders0.31%
Institutions1.59%
Technical
SMA 500.0201 (-7.6%)
SMA 2000.0786 (-76.3%)
Beta0.86
S&P 52W Chg27.94%
Avg Vol (30d)5.84M
Avg Vol (10d)3.07M
Technical Indicators
RSI (14)46.8
MACD-0.0006
MACD Signal-0.0008
MACD Hist.+0.0002
BB Upper0.0227 EUR
BB Middle0.0201 EUR
BB Lower0.0176 EUR
BB Width25.39%
ATR (14)0.0026 EUR
Vol Ratio (20d)0.10x